Community Health Systems Inc. (CYH) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Community Health Systems Inc. (CYH) dropped -9.40% to $2.41, trading at 13% of its 52-week range ($2.19 – $3.93). Stretched risk/reward at current multiples (14% return on capital) under elevated 10-year interest-rate pressure.
Community Health Systems (NYSE:CYH) reported third-quarter 2026 adjusted EBITDA of $280 million, as higher uninsured utilization and softer commercial elective-procedure demand weighed on payer and service mix despite gr
Community Health Systems entered this Q3 2026 report as a deeply discounted healthcare stock, trading at a P/E of 9.1x while peers were priced considerably higher. The headline this quarter was a return to loss making, w
Insurance disenrollment drives uninsured volume surge amid margin pressure.
Community Health Systems, Inc. (CYH) Q3 2026 Earnings Call October 29, 2026 11:00 AM EDTCompany ParticipantsAnton Hie - Vice President of Investor...
Moby summary of Community Health Systems, Inc.'s Q3 2026 earnings call
Community Health Sys (NYSE:CYH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75% to $210.01.
U.S. stock futures were mixed as ServiceNow plunged 18.5% after missing earnings estimates, while Fortinet, Sprouts and Alphabet also fell.
While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare t
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -1.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CYH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CYH. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Community Health Systems Inc. (CYH) ranks #452 by composite RQD confidence (46/100, grade D) and #506 by equity capitalization ($339.8M). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CYH at 46/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CYH
ACTIVE
Community Health Systems Inc. | D | 46/100 | — | 85.1% | 13.5% | -9.40% | $339.8M | Benchmark Subject |
| SNDA Sonida Senior Living Inc. | D | 45/100 | — | — | — | +1.94% | $1.65B | /snda-vs-cyh → |
| HCSG Healthcare Services Group Inc. | B- | 70/100 | 28.2x | 13.0% | 11.6% | +2.58% | $1.66B | /hcsg-vs-cyh → |
| ARDT Ardent Health Inc. | C+ | 67/100 | 12.8x | — | 10.5% | +3.10% | $1.73B | /ardt-vs-cyh → |
| MD Pediatrix Medical Group Inc. | B | 74/100 | 14.3x | — | 33.6% | +0.93% | $2.37B | /md-vs-cyh → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Community Health Systems Inc. (CYH) reported GAAP revenue of $12.48B (-1.2% vs. FY2024 revenue of $12.63B , and -0.0% cumulative change since FY2023) , GAAP net income of $509.0M, operating cash flow of $543.0M, and free cash flow of $208.0M (+73.3% YoY). On the balance sheet, CYH closed FY2025 with $13.20B in total assets against $10.38B in total debt (Altman Z-Score: 1.05, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $12.48B | $509.0M | $543.0M | $208.0M | $13.20B | $10.38B |
| FY2024 (FY) | 2024-12-31 | $12.63B | -$516.0M | $480.0M | $120.0M | $14.05B | $11.43B |
| FY2023 (FY) | 2023-12-31 | $12.49B | -$133.0M | $210.0M | $210.0M | — | — |
As of 2026-11-01, Community Health Systems Inc. (NYSE: CYH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $2.41 (-9.40% 1D, market cap $339.8M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, CYH ranks #452 in composite RQD confidence.
Within the Health Care sector (Hospital/Nursing Management), CYH carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 85.1%, and ROIC of 13.5%. By comparison, SNDA (Sonida Senior Living Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $1.65B) and HCSG (Healthcare Services Group Inc.) posts a B- grade (70/100 RQD, P/E 28.2x, ROIC 11.6%, cap $1.66B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).
Per CYH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001108109), Community Health Systems Inc. generated $12.48B in revenue (-1.2% YoY), $509.0M in net income, and $208.0M in free cash flow against $13.20B in total assets and $10.38B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
CYH last traded at $2.41 (-9.40% on volume of 8,035,342 shares), positioning the stock -16.03% below its 50-day simple moving average ($2.87) and -20.46% below its 200-day simple moving average ($3.03). Across its 52-week range of $2.19 to $3.93, CYH sits at the 12.6% percentile with a 14-day RSI of 29.1 (OVERSOLD (<32)) and an implied next-earnings move of ±10.5% ($2.16 to $2.66).
Why CYH Stock dropped -9.40% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (14% return on capital) under elevated 10-year interest-rate pressure.